| Product Name | MF | CAS | Details |
|---|
| Fosrolapitant | C27H29F6N2O8P | 2573694-38-7 | Details |
| ALKBH5-IN-3 | C11H7F3N2O3 | 1505579-77-0 | Details |
| Antho-riamide I | C30H43N7O6 | 139026-54-3 | Details |
| TMV-IN-12 | C19H17N3O3 | 2861919-00-6 | Details |
| RIPK1-IN-26 | C15H20FNO2 | 2252271-96-6 | Details |
| Cyy-272 | 2644673-01-6 | Details |
| W4275 | C25H36N6O3 | 3051650-00-8 | Details |
| IL-17-IN-2 | C26H30F5N7O2 | 3058278-46-6 | Details |
| FTY720-C2 | C21H35NO3 | 249289-10-9 | Details |
| Inosine 5′-diphosphate sodium | C10H17N4NaO12P2 | 81012-88-6 | Details |
| DLCI-1 | C12H14N2S | 2244569-14-8 | Details |
| AAZ-A 154 | C14H20N2O | 2481740-94-5 | Details |
| Nispomeben | C21H27NO4 | 1443133-41-2 | Details |
| AAZ-A 154 mesylate | C14H20N2O.CH4O3S | 2930846-03-8 | Details |
| Gpr35 modulator 3 | C25H19FN6O2 | 3055887-18-5 | Details |
| C.I. Pigment Red 60 | C17H9N2Na3O9S2 | 1836-22-2 | Details |
| C.I. 37545 | C19H17NO4 | 92-73-9 | Details |
| BMS-986104 | C22H35NO | 1622180-31-7 | Details |
| AI 3-25488 | C11H4F20O | 307-70-0 | Details |
| 2-fluoro Deschloroketamine hydrochloride | C13H17ClFNO | 111982-49-1 | Details |
| Advastab TM 188 | C36H72O4S2Sn | 26401-97-8 | Details |
| Apazone dihydrate | C16H24N4O4 | 22304-30-9 | Details |
| Dansyl-NECA | C30H40N8O6S | 219982-12-4 | Details |
| PDE5-IN-8 | C22H20ClN3O2 | 1233518-60-9 | Details |
| Ulacamten | C21H25F2N3O3 | 2830607-59-3 | Details |
| CGamF | 168912-70-7 | Details |
| AC10142A | 2963581-29-3 | Details |
| Cefamandole | C18H18N6O5S2 | 34444-01-4 | Details |
| Phenyl(9H-purin-6-yl)amine | C11H9N5 | 1210-66-8 | Details |
| Alazopeptin monohydrate | C15H22N6O6 | 1397-85-9 | Details |
| JW-65 | C18H13Cl2F3N4O2 | 2763378-71-6 | Details |
| Veonetinib | C27H28FN3O4 | 1210828-09-3 | Details |
| Antifungal agent 113 | C23H20O5 | 1373311-69-3 | Details |
| SCOTfluor 510 Fmoc-Dapa-OHNew | C24H19N5O6Se | 3023933-33-4 | Details |
| eSM156 | Details |
| Cartap hydrochloride | C7H16ClN3O2S2 | 15263-52-2 | Details |
| Dioctanoylphosphatidic acid sodium | C19H35Na2O8P | 321883-54-9 | Details |
| Pyrazophos | C14H20N3O5PS | 13457-18-6 | Details |
| Janelia Fluor 525, Haloalkan | C37H38ClF4N3O6 | 1811539-37-3 | Details |
| Remlifanserin | C24H29F2N3O2 | 2289704-13-6 | Details |
| D-688 | 2276762-07-1 | Details |
| NOX2-IN-2 diTFA | 2648709-80-0 | Details |
| SARS-CoV-2 Mpro-IN-28 | C14H17NO3Se | 2443360-60-7 | Details |
| (-)-5-HT2C agonist-3 | 2104810-16-2 | Details |
| And1 degrader 1 | C26H27Cl2N3O | 3029132-46-2 | Details |
| JNK-1-IN-4 | C22H25BrN6O3 | 3047795-60-5 | Details |
| BIO399 | Details |
| α-Synuclein modulator 1 | C21H23N3O3 | 3058709-40-0 | Details |
| Antitumor agent-187 | C24H26N2O7 | 2879230-64-3 | Details |
| BTK-IN-38 | C27H26F2N4O2 | 2758410-51-2 | Details |
| β-Galactosyl-C18-ceramide | C42H81NO8 | 36271-49-5 | Details |
| D4-Ribavirin | C8H10N4O3 | 131922-28-6 | Details |
| Dehydroindapamide | C16H14ClN3O3S | 63968-75-2 | Details |
| Rp-cAMPS | C16H27N6O5PS | 73208-40-9 | Details |
| fMIFL | C27H42N4O6S | 112275-26-0 | Details |
| Menoctone | C24H32O3 | 14561-42-3 | Details |
| CDK2/4-IN-2 | C18H20F3N7O3S2 | 3034898-59-1 | Details |
| Nedemelteon | C15H18N2O2 | 1000334-38-2 | Details |
| RTI-122 | C29H34FN3O3 | 3034664-39-3 | Details |
| GSK268 | Details |
| AI 3-27211 | C8H15O4PS2 | 3659-04-9 | Details |
| WAY 163909 hydrochloride | C14H18N2.ClH | 428868-35-3 | Details |
| S-(-)-Aminoglutethimide D-tartrate | C17H22N2O8 | 57288-04-7 | Details |
| 15:0 PG sodium | C69H135Na2O16P | 322647-32-5 | Details |
| Sphingomyelin (d18:1/12:0) | C35H71N2O6P | 474923-21-2 | Details |
| α-Amylase-IN-9 | C13H13FN2O2S | 301359-47-7 | Details |
| EpoY | C15H17NO7 | 245660-13-3 | Details |
| Hinnuliquinone | C32H30N2O4 | 78860-37-4 | Details |
| 1-Stearoyl-sn-glycerol 3-phosphate sodium | C21H41Na2O7P | 325465-92-7 | Details |
| KL-1156 | C17H17NO4 | 819868-62-7 | Details |
| L-368899 free base | C26H42N4O5S2 | 148927-60-0 | Details |
| BAY-405 | C25H23F5N4O3 | 2442532-66-1 | Details |
| DNs-Rh | C32H18N6O15S2 | 1028386-82-4 | Details |
| KP-544 | C18H19ClN4O | 393856-87-6 | Details |
| GC 10284 | C15H21N2O3PS2 | 16231-76-8 | Details |
| Fluorescein O-acrylate | C23H14O6 | 193419-86-2 | Details |
| DOCP | C43H82NO8P | 1360461-57-9 | Details |
| POSH-IN-2 | C22H16N2O2 | 348145-43-7 | Details |
| A3AR antagonist 5 | C18H16N2O2S | 333436-43-4 | Details |
| Naftypramide | C19H26N2O | 1505-95-9 | Details |
| Isoxathion | C13H16NO4PS | 18854-01-8 | Details |
| Cismethrin | C22H26O3 | 35764-59-1 | Details |
| L 640876 | C22H21N7O3S2 | 77527-71-0 | Details |
| NOD1-IN-1 | C16H14ClN3O3 | 687627-78-7 | Details |
| DOR agonist 2 | 1212540-02-7 | Details |
| YM-I-26 | C28H33ClN2O5S2 | 2585015-90-1 | Details |
| Anti-osteoporosis agent-11 | C23H17NO2Se2 | 2869099-50-1 | Details |
| Keap1-Nrf2-IN-22 | C25H22N2O6S | 2955083-85-7 | Details |
| PPARδ agonist 11 | C19H15F3N2O3S2 | 2982696-04-6 | Details |
| JMS-175-2 | C23H19Cl4N5O3 | 3042887-70-4 | Details |
| FK-3657 | C30H27Cl2N5O4 | 167838-64-4 | Details |
| Hsp110-STAT3 interaction-IN-1 | C23H31N3O4S | 882582-26-5 | Details |
| KCG 1 | C13H18O2 | 139036-51-4 | Details |
| ATG12-IN-1 | C23H15ClN4O2 | 2950162-68-0 | Details |
| CB1/2 receptor-1 | 1260669-31-5 | Details |
| DNA Gyrase-IN-13 | 2247443-72-5 | Details |
| A-889425 | C19H18F3N3O3S | 1072921-02-8 | Details |
| PARP1-IN-31 | C22H15ClFN3O2 | 684234-60-4 | Details |
| Iothalamate sodium | C11H8I3N2NaO4 | 1225-20-3 | Details |
| Japonilure | C14H24O2 | 64726-91-6 | Details |
| Product Total： Product Page： | ||||
| 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 | ||||